Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Prostate cancer
Closed
Phase 2
This trial is looking at pembrolizumab for prostate cancer that has spread and hormone treatment is no longer working.
It is for men with prostate cancer that has spread and getting worse despite having hormones or surgery to remove the testicles. This is castration resistant metastatic prostate cancer.
Recruitment start: 27 November 2018
Recruitment end: 18 August 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Johann de Bono
Institute of Cancer Research (ICR)
Merck, Sharp & Dohme
Last reviewed: 29 December 2023
CRUK internal database number: 17189
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
